Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-15-014238
Filing Date
2015-03-05
Accepted
2015-03-05 16:18:16
Documents
13
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v402704_10k.htm 10-K 576213
2 EXHIBIT 21.1 v402704_ex21-1.htm EX-21.1 2749
3 EXHIBIT 23.1 v402704_ex23-1.htm EX-23.1 3677
4 EXHIBIT 31.1 v402704_ex31-1.htm EX-31.1 11332
5 EXHIBIT 31.2 v402704_ex31-2.htm EX-31.2 11397
6 EXHIBIT 32.1 v402704_ex32-1.htm EX-32.1 4794
7 EXHIBIT 32.2 v402704_ex32-2.htm EX-32.2 4898
  Complete submission text file 0001144204-15-014238.txt   6061650

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT enzn-20141231.xml EX-101.INS 846678
9 XBRL TAXONOMY EXTENSION SCHEMA enzn-20141231.xsd EX-101.SCH 63299
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enzn-20141231_cal.xml EX-101.CAL 47981
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enzn-20141231_def.xml EX-101.DEF 275934
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20141231_lab.xml EX-101.LAB 380297
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20141231_pre.xml EX-101.PRE 335219
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36435 | Film No.: 15677594
SIC: 2836 Biological Products, (No Diagnostic Substances)